21:53:52Canada

Pharming Group N.V. (PHAR)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
376,134,000 26.6%
Net income
2,851,000
Gross profit
330,634,000
Operating income
25,842,000
Earnings per share
0.00
R&D expense
100,367,000

Growth and profitability

Gross margin
87.90
Operating margin
6.87
Net margin
0.76
Return on equity
1.03
Return on assets
0.57
Free cash flow margin
14.35

Balance sheet

Total assets
499,963,000
Shareholders' equity
277,102,000
Cash and equivalents
145,305,000
Current ratio
2.59

Cash flow and ratios

Operating cash flow
54,708,000
Free cash flow
53,959,000
Interest coverage
131.85

Shareholder returns

Shares outstanding
701,680,440
Book value per share
0.39
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Leiden, P7
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Pharming Group N.V. trades on NASDAQ under the ticker symbol PHAR. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis